iPhantom: A Framework for Automated Creation of Individualized Computational Phantoms and Its Application to CT Organ Dosimetry.


Journal

IEEE journal of biomedical and health informatics
ISSN: 2168-2208
Titre abrégé: IEEE J Biomed Health Inform
Pays: United States
ID NLM: 101604520

Informations de publication

Date de publication:
08 2021
Historique:
pubmed: 3 3 2021
medline: 25 9 2021
entrez: 2 3 2021
Statut: ppublish

Résumé

This study aims to develop and validate a novel framework, iPhantom, for automated creation of patient-specific phantoms or "digital-twins (DT)" using patient medical images. The framework is applied to assess radiation dose to radiosensitive organs in CT imaging of individual patients. Given a volume of patient CT images, iPhantom segments selected anchor organs and structures (e.g., liver, bones, pancreas) using a learning-based model developed for multi-organ CT segmentation. Organs which are challenging to segment (e.g., intestines) are incorporated from a matched phantom template, using a diffeomorphic registration model developed for multi-organ phantom-voxels. The resulting digital-twin phantoms are used to assess organ doses during routine CT exams. iPhantom was validated on both with a set of XCAT digital phantoms (n = 50) and an independent clinical dataset (n = 10) with similar accuracy. iPhantom precisely predicted all organ locations yielding Dice Similarity Coefficients (DSC) 0.6 - 1 for anchor organs and DSC of 0.3-0.9 for all other organs. iPhantom showed <10% errors in estimated radiation dose for the majority of organs, which was notably superior to the state-of-the-art baseline method (20-35% dose errors). iPhantom enables automated and accurate creation of patient-specific phantoms and, for the first time, provides sufficient and automated patient-specific dose estimates for CT dosimetry. The new framework brings the creation and application of CHPs (computational human phantoms) to the level of individual CHPs through automation, achieving wide and precise organ localization, paving the way for clinical monitoring, personalized optimization, and large-scale research.

Identifiants

pubmed: 33651703
doi: 10.1109/JBHI.2021.3063080
pmc: PMC8502243
mid: NIHMS1731009
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

3061-3072

Subventions

Organisme : NIBIB NIH HHS
ID : P41 EB028744
Pays : United States
Organisme : NIBIB NIH HHS
ID : R01 EB001838
Pays : United States

Commentaires et corrections

Type : ErratumIn

Références

Phys Med Biol. 2019 Nov 04;64(21):215020
pubmed: 31539892
Phys Med Biol. 2002 Jan 7;47(1):89-106
pubmed: 11814230
Med Phys. 2013 Apr;40(4):043701
pubmed: 23556927
Phys Med Biol. 2007 Dec 7;52(23):7023-44
pubmed: 18029991
Med Phys. 2015 Aug;42(8):4719-26
pubmed: 26233199
Med Phys. 2015 Apr;42(4):1575-85
pubmed: 25832048
IEEE Trans Med Imaging. 2018 Aug;37(8):1822-1834
pubmed: 29994628
Pediatr Radiol. 2014 Oct;44 Suppl 3:460-7
pubmed: 25304705
IEEE Trans Radiat Plasma Med Sci. 2019 Jan;3(1):1-23
pubmed: 30740582
Med Phys. 2020 Jun;47(6):2526-2536
pubmed: 32155670
Med Image Anal. 2008 Feb;12(1):26-41
pubmed: 17659998
Neuroimage. 2011 Feb 1;54(3):2033-44
pubmed: 20851191
Phys Med Biol. 2016 May 21;61(10):3935-54
pubmed: 27119974
Med Phys. 2009 Nov;36(11):4878-80
pubmed: 19994495
Hippocampus. 2009 Jun;19(6):565-71
pubmed: 19437413
Phys Med Biol. 2014 Sep 21;59(18):R233-302
pubmed: 25144730
Int J Biomed Imaging. 2011;2011:481064
pubmed: 21960989
Med Phys. 2005 Dec;32(12):3537-48
pubmed: 16475752
IEEE Trans Med Imaging. 2018 Mar;37(3):680-692
pubmed: 28809677
Comput Med Imaging Graph. 2019 Jul;75:24-33
pubmed: 31129477
Phys Med Biol. 2014 Aug 21;59(16):4525-48
pubmed: 25069102
Med Phys. 2012 Nov;39(11):6550-71
pubmed: 23127050
J Anat. 2018 Jul;233(1):121-134
pubmed: 29663370
IEEE Trans Med Imaging. 2013 Jul;32(7):1153-90
pubmed: 23739795
J Med Imaging (Bellingham). 2016 Oct;3(4):043502
pubmed: 27921070

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH